Market Tracker weekly round-up—29 March 2018

Market Tracker weekly round-up—29 March 2018

Weekly round-up of the latest corporate announcements, including a recommended all-cash offer by the Royal Bank of Scotland Group for FreeAgent Holdings, a possible offer by Takeda International for Shire, a recommended cash and share offer by CME Group for NEX Group, an IPO by Odyssean Investment Trust, secondary offers by Bushveld Minerals, Summit Theraputics and Restore plc, returns of value by Ferguson and GKN, listing rules transactions by GlobalData, RM2 International, Action Hotels, GlaxoSmithKline, Chariot Oil & Gas, Summit Theraputics, and JD Sports Fashion, and AGM notices by Merlin Entertainments, IMI, National Express Group, Barr (A.G.), Ferguson, Bgeo Group, Staffline Group, and Bodycote.

The daily round-up covers all deals announced until 12 noon on the date of the daily round-up from 12 noon on the previous business day. Any deals announced after this time frame will be included in the following daily round-up.

The information contained in the daily round up is transferred to the weekly round up on a Friday. All announcement data is republished in the monthly round up at the end of the month. To access previous announcements please visit the Market Tracker section or the News tab on the Corporate homepage

Market Tracker—Statement of scope

Market Tracker deal analysis tool

New deals (and AGMs) announced:

AGMs

Announcement date Issuer Industry sector Key information
29 March 2018 Bodycote plc Engineering & manufacturing Bodycote has announced that its 2018 AGM will be held on 30 May 2018.
29 March 2018 Staffline Group plc Professional services

Subscription Form

Related Articles:
Latest Articles:

Already a subscriber? Login
RELX (UK) Limited, trading as LexisNexis, and our LexisNexis Legal & Professional group companies will contact you to confirm your email address. You can manage your communication preferences via our Preference Centre. You can learn more about how we handle your personal data and your rights by reviewing our  Privacy Policy.

Access this article and thousands of others like it free by subscribing to our blog.

Read full article

Already a subscriber? Login

About the author: